Deutsch English Français

Contact

EP1066033

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1066033

EP1066033 - SMILAGENIN AND ANZUROGENIN-D FOR THE TREATMENT OF ALZHEIMER'S DISEASE [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 03.11.2006 Database last updated on 13.07.2024
Most recent event Tooltip	05.12.2008	Lapse of the patent in a contracting state New state(s): CY	published on 07.01.2009 [2009/02]
Applicant(s)	For all designated states PHYTOPHARM PLC Corpus Christi House, 9 West Street Godmanchester Cambridgeshire PE18 8HG / GB
	[2005/52]
Former [2001/02]	For all designated states PHYTOPHARM PLC Corpus Christi House, 9 West Street Godmanchester, Cambridgeshire PE18 8HG / GB
Inventor(s)	01 / XIA, Zongqin Flat 403, Block 8, 1 Jian-De Road Shanghai 200025 / CN
	02 / HU, Yaer Flat 1209, Block 1, Lane 357, Ma-Dang Road Sanghai 200025 / CN
	03 / RUBIN, Ian Hall Farm House, 9 High Street Castle Donington, Leicester LE74 2PP / GB
	04 / BROSTOFF, Jonathan 34 Fitzjohn Avenue London NW3 5NB / GB
	05 / WHITTLE, Brian Mereclose, Hull Road Hornsea, East Yorkshire HU18 1RJ / GB
	06 / WANG, Weijun 10 Brecon Way, Hinchingbrooke Park Huntingdon, Cams PE18 8XX / GB
	07 / GUNNING, Phil 37a King Street Saffron Walden, Essex CB10 1EU / GB
	[2001/02]
Representative(s)	Brown, David Leslie, et al Haseltine Lake Kempner LLP Redcliff Quay 120 Redcliff Street Bristol BS1 6HU / GB
	[N/P]
Former [2004/39]	Brown, David Leslie, et al HASELTINE LAKE, Redcliff Quay 120 Redcliff Street Bristol BS1 6HU / GB
Former [2001/02]	Abrams, Michael John Haseltine Lake & Co, Imperial House, 15-19 Kingsway London WC2B 6UD / GB
Application number, filing date	99913462.0	26.03.1999
	[2001/02]
	WO1999GB00960
Priority number, date	GB19980006513	26.03.1998 Original published format: GB 9806513
	GB19990005275	08.03.1999 Original published format: GB 9905275
	[2001/02]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9948482
	Date:	30.09.1999
	Language:	EN
	[1999/39]
	Type:	A1 Application with search report
	No.:	EP1066033
	Date:	10.01.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 30.09.1999 takes the place of the publication of the European patent application.
	[2001/02]
	Type:	B1 Patent specification
	No.:	EP1066033
	Date:	28.12.2005
	Language:	EN
	[2005/52]
Search report(s)	International search report - published on:	EP	30.09.1999
Classification	IPC:	A61K31/00, A61P25/28	[2004/40]
	CPC:	A61K31/704 (EP,US); A61K35/00 (KR); A61K31/58 (EP,US); A61K31/7048 (EP,US); A61K36/88 (EP,US); A61K36/896 (EP,US); (+) A61K36/8964 (EP,US); A61K36/8965 (EP,US); A61K36/90 (EP,US); A61P21/04 (EP); A61P25/00 (EP); A61P25/16 (EP); A61P25/18 (EP); A61P25/28 (EP); A61P39/00 (EP); A61P39/02 (EP); A61P39/06 (EP); A61P43/00 (EP); A61P9/00 (EP); A61P9/02 (EP); G01N33/944 (EP,US) (-)
	Former IPC [2001/02]	A61K31/00
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/02]
Extension states	AL	25.10.2000
	LT	25.10.2000
	LV	25.10.2000
	MK	25.10.2000
	RO	25.10.2000
	SI	25.10.2000
Title	German:	SMILAGENIN UND ANZUROGENIN-D ZUR BEHANDLUNG DER ALZHEIMERISCHEN KRANKHEIT	[2001/02]
	English:	SMILAGENIN AND ANZUROGENIN-D FOR THE TREATMENT OF ALZHEIMER'S DISEASE	[2001/02]
	French:	SMILAGENINE ET ANZUROGENINE D ET LEUR UTILISATION	[2001/02]
Entry into regional phase	25.10.2000	National basic fee paid
	25.10.2000	Designation fee(s) paid
	25.10.2000	Examination fee paid
Examination procedure	26.10.1999	Request for preliminary examination filed International Preliminary Examining Authority: EP
	25.10.2000	Examination requested [2001/02]
	16.07.2001	Despatch of a communication from the examining division (Time limit: M08)
	24.06.2002	Reply to a communication from the examining division
	15.07.2002	Despatch of a communication from the examining division (Time limit: M04)
	12.03.2003	Reply to a communication from the examining division
	26.03.2003	Despatch of a communication from the examining division (Time limit: M04)
	11.09.2003	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	18.11.2003	Reply to a communication from the examining division
	18.12.2003	Despatch of a communication from the examining division (Time limit: M04)
	19.04.2004	Reply to a communication from the examining division
	06.05.2004	Despatch of a communication from the examining division (Time limit: M04)
	29.07.2004	Reply to a communication from the examining division
	14.09.2004	Communication of intention to grant the patent
	10.01.2005	Fee for grant paid
	10.01.2005	Fee for publishing/printing paid
Opposition(s)	29.09.2006	No opposition filed within time limit [2006/49]
Request for further processing for:	18.11.2003	Request for further processing filed
	10.11.2003	Full payment received (date of receipt of payment) Request granted
	02.12.2003	Decision despatched
	12.03.2003	Request for further processing filed
	10.03.2003	Full payment received (date of receipt of payment) Request granted
	24.03.2003	Decision despatched
	24.06.2002	Request for further processing filed
	24.06.2002	Full payment received (date of receipt of payment) Request granted
	10.07.2002	Decision despatched
Fees paid	Renewal fee
	05.03.2001	Renewal fee patent year 03
	27.03.2002	Renewal fee patent year 04
	26.03.2003	Renewal fee patent year 05
	29.03.2004	Renewal fee patent year 06
	31.03.2005	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	28.12.2005
	FI	28.12.2005
	NL	28.12.2005
	DK	28.03.2006
	GR	28.03.2006
	SE	28.03.2006
	PT	29.05.2006
	[2009/02]
Former [2007/02]	FI	28.12.2005
	NL	28.12.2005
	DK	28.03.2006
	GR	28.03.2006
	SE	28.03.2006
	PT	29.05.2006
Former [2006/49]	FI	28.12.2005
	NL	28.12.2005
	GR	28.03.2006
	SE	28.03.2006
	PT	29.05.2006
Former [2006/45]	FI	28.12.2005
	NL	28.12.2005
	GR	28.03.2006
	SE	28.03.2006
Former [2006/38]	FI	28.12.2005
	GR	28.03.2006
	SE	28.03.2006
Former [2006/27]	FI	28.12.2005
	SE	28.03.2006
Former [2006/24]	FI	28.12.2005
Cited in	International search	[DX]DE4303214 (MARKS WOLFGANG [DE]) [DX] 1-10 * page 6, lines 15-26; claims 1,14 *;
		[D]CN1096031 (SHANGHAI NO 2 MEDICAL UNIV [CN]);
		[E]WO9916786 (INST RADIATION MED AMMS PLA [CN], et al) [E] 1-10 * abstract *;
		[X] - N. YI ET AL., "Sarsasapogenin: Mechanism in treating senile dementia", PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM OF THE INTERNATIONAL ISOTOPE SOCIETY, PHILADELPHIA, 1997, pages 315 - 320, XP002117140 [X] 1-10 * the whole document *
		[X] - STN INTERNATIONAL. FILE CHEMICAL ABSTRACTS. AN=123:266081, XP002117141 [X] 1-10 * abstract *
		[A] - G. BLUDEN ET AL., "Steroidal sapogenins from leaves of Agaveae species", STN INTERNATIONAL. FILE BIOSIS. AN=1979:172390, XP002117142 [A] 1-10 * abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p